<code id='7D16DCCBEF'></code><style id='7D16DCCBEF'></style>
    • <acronym id='7D16DCCBEF'></acronym>
      <center id='7D16DCCBEF'><center id='7D16DCCBEF'><tfoot id='7D16DCCBEF'></tfoot></center><abbr id='7D16DCCBEF'><dir id='7D16DCCBEF'><tfoot id='7D16DCCBEF'></tfoot><noframes id='7D16DCCBEF'>

    • <optgroup id='7D16DCCBEF'><strike id='7D16DCCBEF'><sup id='7D16DCCBEF'></sup></strike><code id='7D16DCCBEF'></code></optgroup>
        1. <b id='7D16DCCBEF'><label id='7D16DCCBEF'><select id='7D16DCCBEF'><dt id='7D16DCCBEF'><span id='7D16DCCBEF'></span></dt></select></label></b><u id='7D16DCCBEF'></u>
          <i id='7D16DCCBEF'><strike id='7D16DCCBEF'><tt id='7D16DCCBEF'><pre id='7D16DCCBEF'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:27247
          J.P. Morgan office building at night -- JPM health business coverage from STAT
          Adobe

          SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so. 

          Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

          advertisement

          Their message? We’re still here. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK
          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Why Talkspace is targeting Medicare, a tricky market

          AdobeOverthelastfewyears,virtualmentalhealthcompanyTalkspacehasbeenonarelentlessquesttoconquertheins